EBV-Associated Lymphoma Consortium Annual Meeting (Abstract): Submission #4
Submission information
Submission Number: 4
Submission ID: 150768
Submission UUID: 3c6f0dbc-efc3-4dbb-9ea0-27aaa8c50684
Submission URI: /nci/ealv/venue/abstract
Submission Update: /nci/ealv/venue/abstract?token=64aPD2WhlZzZdzmakmTE2bhiqBlRnyHX_DQ85sXpams
Created: Wed, 09/03/2025 - 13:22
Completed: Wed, 09/03/2025 - 13:22
Changed: Wed, 09/03/2025 - 13:22
Remote IP address: 10.208.28.30
Submitted by: Anonymous
Language: English
Is draft: No
serial: '4'
sid: '150768'
uuid: 3c6f0dbc-efc3-4dbb-9ea0-27aaa8c50684
uri: /nci/ealv/venue/abstract
created: '1756920154'
completed: '1756920154'
changed: '1756920154'
in_draft: '0'
current_page: ''
remote_addr: 10.208.28.30
uid: '0'
langcode: en
webform_id: ebv_ass_lym_consorti_abstrac
entity_type: node
entity_id: '1883'
locked: '0'
sticky: '0'
notes: ''
metatag: meta
data:
degree_s_: 'MD, PhD'
email: bgewurz@bwh.harvard.edu
first_name: Ben
keywords_abstracts: ''
last_name: Gewurz
middle_initial: E.
organization: "Brigham & Women's Hospital"
organization_address:
address: ''
address_2: ''
city: Boston
country: ''
postal_code: ''
state_province: ''
summary: 'Much remains to be learned about how EBV latency genes and host epigenetic factors cross-regulate one-another, with relevance to the development of novel host-targeted therapeutic approaches. While linker histone H1 are B-cell tumor suppressors mutated with striking frequency across EBV-negative lymphomas, little is known about histone H1 roles in EBV-mediated lymphomagenesis and lymphomas, how EBV latency genes suppress H1 expression or how H1 in turn cross-regulates the EBV epigenome. We build upon our observation that EBV strongly reduces linker histone H1 expression in newly infected B-cells as they transform into lymphoblastoid cells with the latency III program and in lymphoblastoid cell lines. We characterized how EBV suppresses histone H1 expression in B cell transformation. ATACseq highlighted that EBV latency III reduced H1 gene chromatin accessibility in Burkitt B cells, but not in newly transformed peripheral blood B cells or in LCLs. Histone H1 genes retained activating chromatin marks following B cell EBV infection and in LCLs. Instead, we observed reduction in histone H1 locus long-range chromatin contacts. While infection by EBNA3A/C double knockout (KO) EBV reduced H1 gene chromatin accessibility in LCLs, we observed increased H1 gene expression in B cells infected by EBNA3A KO EBV. However, EBV must maintain a some H1 expression to maintain viral latency. Relatedly, we investigated how H1 abundance correlated with B cell genome-wide H3K36me2 and H3K27me3 epigenetic marks, since the H3K36me2 epigenetic writers compete with H1 at DNA sites, whereas H1 promotes repressive H3K27me3 deposition to silence target genes. We used ChIP-seq to define target genes with the most differential H3K36me2 and H3K27me3 marks in latency I vs III states with elevated versus repressed H1 expression, respectively. Together, these studies provide key insights into how EBV latency genes and linker histone H1 cross-regulate one-another.'
title: 'Associate Professor'
ttile: 'EBV Latency Gene and Linker Histone H1 Cross-regulation in B cell lymphomagenesis'